# Central Laboratory Services for Clinical Trial

The Federal Agency for Disruptive Innovation - SPRIND GmbH ("SPRIND") - aims to create new disruptive innovations from Germany.  That means products, services and systems that make all our lives noticeably and sustainably better.  To achieve this, SPRIND brings together new thin…

Source: QUOTA CÔTE — https://quotacote.com/opportunites/central-laboratory-services-for-clinical-trial-allemagne--b090a511-c5c5-4cb6-9a3f-efe12c0d7522
Last checked by QUOTA: 2026-10-06
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Allemagne [FACT]
- Deadline: 2026-11-04 [FACT]
- Last checked by QUOTA: 2026-10-06 [FACT]
- Sector (QUOTA normalisation): Autre [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Allemagne
- funder: BiconY Therapeutics GmbH
- buyer: BiconY Therapeutics GmbH

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.